Myriad Genetics, Inc. (MYGN)
3.265
-0.10
(-2.83%)
USD |
NASDAQ |
Sep 11, 13:22
Myriad Genetics Cash from Operations (Annual) : 1.80M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.80M |
| December 31, 2024 | -8.70M |
| December 31, 2023 | -110.90M |
| December 31, 2022 | -107.00M |
| December 31, 2021 | 17.00M |
| June 30, 2020 | 59.70M |
| June 30, 2019 | 83.70M |
| June 30, 2018 | 115.90M |
| June 30, 2017 | 106.20M |
| June 30, 2016 | 166.30M |
| June 30, 2015 | 140.50M |
| June 30, 2014 | 190.21M |
| June 30, 2013 | 173.87M |
| June 30, 2012 | 141.85M |
| June 30, 2011 | 130.76M |
| Date | Value |
|---|---|
| June 30, 2010 | 155.09M |
| June 30, 2009 | 84.04M |
| June 30, 2008 | 103.74M |
| June 30, 2007 | -25.85M |
| June 30, 2006 | -28.03M |
| June 30, 2005 | -23.30M |
| June 30, 2004 | -30.88M |
| June 30, 2003 | -46.54M |
| June 30, 2002 | -16.31M |
| June 30, 2001 | -3.775M |
| June 30, 2000 | 17.16M |
| June 30, 1999 | -14.14M |
| June 30, 1998 | -7.029M |
| June 30, 1997 | -6.582M |
| June 30, 1996 | 1.420M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Natera, Inc. | 215.30M |
| Sera Prognostics, Inc. | -25.62M |
| BioRestorative Therapies, Inc. | -10.79M |
| CareDx, Inc. | 42.03M |
| Exagen, Inc. | -13.62M |